Skip to main content
Premium Trial:

Request an Annual Quote

Bayer CropScience to Use Fluidigm Tools in Breeding Programs

NEW YORK (GenomeWeb News) – Bayer CropScience will use Fluidigm's integrated fluidic circuit (IFC) technologies in its molecular breeding program, Fluidigm said today.

The agricultural branch of Bayer will use Fluidigm's IFC tools under a global, multi-year agreement, for field and vegetable crops, South San Francisco-based Fluidigm said.
Fluidigm's technologies for high-throughput SNP genotyping in molecular breeding projects include the BioMark and the EP1 systems, and its microfluidic-based Dynamic Array.

Traditional breeding experiments required growing new crops, selecting traits, cross-breeding, and growing seeds again to maturity to check results, a process that could take years and even decades, said Fluidigm. But molecular breeding enables breeders to "dramatically decrease cost and timelines to select the best seeds for the market place," the firm said.

Even the capacity of molecular breeding has been limited, the company noted, adding that its technologies increase output more than 10-fold and lowers the cost-per-data point compared with using 384-well plates for genotyping.

Financial terms of the agreement were not released.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.